Actively Recruiting

Phase 2
Age: 18Years - 50Years
All Genders
ID06311890

Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne

Led by Xiyuan Hospital of China Academy of Chinese Medical Sciences · Updated on 2024-03-15

46

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the clinical efficacy, safety, and tolerability of a new photodynamic therapy (PDT) using Chlorin-e6 for treating moderate to severe acne. This study is based on evidence that PDT, especially with photosensitizers like Porphyrin and Chlorin, can reduce skin lesions and microbial load. Chlorin-e6 has shown promise in reducing inflammation and increasing collagen in skin cells, suggesting its potential benefit for acne with high inflammation and scarring risk. Participants will receive acne removal surgery followed by three treatments spaced two weeks apart (plus or minus 3 days). One group will get PDT with Chlorin-e6, and the other will receive a placebo treatment with red light exposure and a chlorin-e6 placebo after surgery. Treatments focus on evaluating the photosensitizer's effects compared to placebo. During the study, researchers will assess changes using the Global Acne Grading System (GAGS) at baseline and multiple follow-up times up to six months after the final treatment. Participants will be monitored for safety, tolerability, and treatment adherence throughout. The study includes a randomized, quadruple-masked design and spans from screening to 6 months post-treatment, with ongoing evaluation of acne severity and participant wellbeing.

CONDITIONS

Brief Title

Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne

Who Can Participate

Age: 18Years - 50Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subject is male or non-pregnant female aged 18 to under 50 years
  • Subject has moderate to severe facial acne vulgaris
  • Subject has provided written informed consent
Not Eligible

You will not qualify if you...

  • Taking photosensitive drugs
  • Allergic to any component of the photosensitizer
  • Allergies to porphyrins or history of photosensitivity
  • Pregnant or lactating women, or planning pregnancy within 3 months
  • Use of oral or topical antibiotics, retinoids, glucocorticoids, peroxybenzoyl, or similar drugs within past 1 month
  • Exposure to sunlight in past 1 month, photoelectric treatment in past 3 months, or facial grinding treatment in past 6 months
  • Using vasodilators, beta blockers, anticoagulants, or drugs causing facial capillary dilation
  • Facial rosacea, atopic dermatitis, hormone-dependent dermatitis, or other facial skin diseases
  • Abnormal blood or urine tests, liver/kidney dysfunction, important organ diseases, or hematopoietic system disorders
  • Participation in other clinical trials concurrently

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Acne Removal Surgery

Duration - 1 day

Participants undergo acne removal surgery before receiving photodynamic therapy or placebo treatment.

1 visit (in-person)

Treatment

Duration - Approximately 6 weeks

Participants receive three photodynamic therapy or placebo treatments with chlorin-e6 at two-week intervals after surgery.

3 treatment visits (in-person) spaced two weeks apart

Follow-up

Duration - 6 months after final treatment

Participants are monitored with assessments of acne severity at 2 weeks, 1 month, 2 months, and 6 months after the final treatment.

4 follow-up visits (in-person)

Trial Site Locations

Total: 1 location

1

Xiyuan Hospital of China Academy of Chinese Medical Sciences Organization

Beijing, China, 100091

Actively Recruiting

Loading map...

Research Team

H

Huiyan Chi, doctor

Y

Yisheng Zhang, doctor

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here